Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)

BMC Medical Genetics

Volumn 11, Issue 1, 2010, Pages

  Solaas, Karianne ^a,b   Legry, Vanessa ^c   Retterstol, Kjetil ^d,e   Berg, Paul R ^f   Holven, Kirsten B ^b   Ferrières, Jean ^g   Amouyel, Philippe ^c   Lien, Sigbjorn ^f   Romeo, Javier ^h   Valtueña, Jara ⁱ   Widhalm, Kurt ^j   Ruiz, Jonatan R ^k   Dallongeville, Jean ^c   Tonstad, Serena ^l   Rootwelt, Helge ^d   Halvorsen, Bente ^d   Nenseter, Marit S ^d   Birkeland, Kare I ^a,b   Thorsby, Per M ^a   Meirhaeghe, Aline ^c   Nebb, Hilde I ^b   more..

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIV LILLE   (France)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e Norwegian Medicines Agency   (Norway)

^f NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^g UNIVERSITÉ DE TOULOUSE   (France)

^h INSTITUTO DEL FRÍO CSIC   (Spain)

ⁱ UNIVERSIDAD POLITÉCNICA DE MADRID   (Spain)

^j MEDICAL UNIVERSITY OF VIENNA   (Austria)

^k KAROLINSKA INSTITUTE   (Sweden)

^l ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEPATIC NUCLEAR FACTOR 4 ALPHA; LIVER X RECEPTOR BETA; NUCLEAR FACTOR I; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; HEPATOCYTE NUCLEAR FACTOR 4; HNF4A PROTEIN, HUMAN; LIVER X RECEPTOR; ORPHAN NUCLEAR RECEPTOR;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BINDING SITE; CELL STRAIN HEPG2; COHORT ANALYSIS; COMPUTER MODEL; CROSS-SECTIONAL STUDY; CYTOGENETICS; DIABETIC OBESITY; DNA BINDING; EUROPE; FRANCE; GENE EXPRESSION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC RISK; GENETIC TRAIT; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRON; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; NUCLEOTIDE SEQUENCE; OBESITY; PHENOTYPE; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSACTIVATION; DNA SEQUENCE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; MIDDLE AGED;

MUS;

ADOLESCENT; ADULT; AGED; ALLELES; BINDING SITES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; EUROPE; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INTRONS; MALE; MIDDLE AGED; NFI TRANSCRIPTION FACTORS; NORWAY; OBESITY; ORPHAN NUCLEAR RECEPTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 77957748003     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-11-144     Document Type: Article

References (32)

1. Bensinger SJ, Tontonoz P. Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 2008, 454:470-477. 10.1038/nature07202, 18650918.
2. Baranowski M. Biological role of liver X receptors. J Physiol Pharmacol 2008, 59(Suppl 7):31-55.
3. Zelcer N, Tontonoz P. Liver X receptors as integrators of metabolic and inflammatory signaling. J Clin Invest 2006, 116:607-614. 10.1172/JCI27883, 1386115, 16511593.
4. Lu TT, Repa JJ, Mangelsdorf DJ. Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J Biol Chem 2001, 276:37735-37738.
5. Zitzer H, Wente W, Brenner MB, Sewing S, Buschard K, Gromada J, Efanov AM. Sterol regulatory element-binding protein 1 mediates liver X receptor-beta-induced increases in insulin secretion and insulin messenger ribonucleic acid levels. Endocrinology 2006, 147:3898-3905. 10.1210/en.2005-1483, 16644917.
6. Janowski BA, Grogan MJ, Jones SA, Wisely GB, Kliewer SA, Corey EJ, Mangelsdorf DJ. Structural requirements of ligands for the oxysterol liver X receptors LXRalpha and LXRbeta. Proc Natl Acad Sci USA 1999, 96:266-271. 10.1073/pnas.96.1.266, 15128, 9874807.
7. Song C, Liao S. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology 2000, 141:4180-4184. 10.1210/en.141.11.4180, 11089551.
8. Song C, Hiipakka RA, Liao S. Selective activation of liver X receptor alpha by 6alpha-hydroxy bile acids and analogs. Steroids 2000, 65:423-427. 10.1016/S0039-128X(00)00127-6, 10936612.
9. Gabbi C, Warner M, Gustafsson JA. Minireview: liver X receptor beta: emerging roles in physiology and diseases. Mol Endocrinol 2009, 23:129-136. 10.1210/me.2008-0398, 19074550.
10. Korach-Andre M, Parini P, Larsson L, Arner A, Steffensen KR, Gustafsson JA. Separate and overlapping metabolic functions of LXRalpha and LXRbeta in C57Bl/6 female mice. Am J Physiol Endocrinol Metab 2010, 298:E167-178. 10.1152/ajpendo.00184.2009, 19690071.
11. Gerin I, Dolinsky VW, Shackman JG, Kennedy RT, Chiang SH, Burant CF, Steffensen KR, Gustafsson JA, Macdougald OA. LXRbeta is required for adipocyte growth, glucose homeostasis, and beta cell function. J Biol Chem 2005, 280:23024-23031. 10.1074/jbc.M412564200, 15831500.
12. Efanov AM, Sewing S, Bokvist K, Gromada J. Liver X receptor activation stimulates insulin secretion via modulation of glucose and lipid metabolism in pancreatic beta-cells. Diabetes 2004, 53(Suppl 3):S75-S78. 10.2337/diabetes.53.suppl_3.S75, 15561926.
13. Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, Park J, Lee KM, Park KG, Lee IK, Kim JB. Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells. Diabetes 2007, 56:1534-1543. 10.2337/db06-1059, 17369526.
14. Schuster GU, Parini P, Wang L, Alberti S, Steffensen KR, Hansson GK, Angelin B, Gustafsson JA. Accumulation of foam cells in liver X receptor-deficient mice. Circulation 2002, 106:1147-1153. 10.1161/01.CIR.0000026802.79202.96, 12196343.
15. Lund EG, Menke JG, Sparrow CP. Liver X receptor agonists as potential therapeutic agents for dyslipidemia and atherosclerosis. Arterioscler Thromb Vasc Biol 2003, 23:1169-1177. 10.1161/01.ATV.0000056743.42348.59, 12615685.
16. Midthjell K, Kruger O, Holmen J, Tverdal A, Claudi T, Bjorndal A, Magnus P. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care 1999, 22:1813-1820. 10.2337/diacare.22.11.1813, 10546013.
17. Thorsby PM, Midthjell K, Gjerlaugsen N, Holmen J, Hanssen KF, Birkeland KI, Berg JP. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study. Scand J Clin Lab Invest 2009, 69:282-287. 10.1080/00365510802538188, 18972257.
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215. 10.1093/nar/16.3.1215, 334765, 3344216.
19. The World Health Organization MONICA Project Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. Int J Epidemiol 1994, 23:505-516. 10.1093/ije/23.3.505, 7960374, The World Health Organization MONICA Project.
20. Cottel D, Dallongeville J, Wagner A, Ruidavets JB, Arveiler D, Ferrieres J, Bingham A, Marecaux N, Ducimetiere P, Amouyel P. The North-East-South gradient of coronary heart disease mortality and case fatality rates in France is consistent with a similar gradient in risk factor clusters. Eur J Epidemiol 2000, 16:317-322. 10.1023/A:1007678526840, 10959938.
21. Moreno LA, Gonzalez-Gross M, Kersting M, Molnar D, De HS, Beghin L, Sjostrom M, Hagstromer M, Manios Y, Gilbert CC, Ortega FB, Dallongeville J, Arcella D, Warnberg J, Hallberg M, Fredriksson H, Maes L, Widhalm K, Kafatos AG, Marcos A. Assessing, understanding and modifying nutritional status, eating habits and physical activity in European adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) Study. Public Health Nutr 2008, 11:288-299. 10.1017/S1368980007000535, 17617932.
22. Moreno LA, De HS, Gonzalez-Gross M, Kersting M, Molnar D, Gottrand F, Barrios L, Sjostrom M, Manios Y, Gilbert CC, Leclercq C, Widhalm K, Kafatos A, Marcos A. Design and implementation of the Healthy Lifestyle in Europe by Nutrition in Adolescence Cross-Sectional Study. Int J Obes (Lond) 2008, 32(Suppl 5):S4-11. 10.1038/ijo.2008.177, 19011652.
23. Legry V, Bokor S, Cottel D, Beghin L, Catasta G, Nagy E, Gonzalez-Gross M, Spinneker A, Stehle P, Molnar D, Amouyel P, Dallongeville J, Meirhaeghe A. Associations between common genetic polymorphisms in angiopoietin-like proteins 3 and 4 and lipid metabolism and adiposity in European adolescents and adults. J Clin Endoc Metab 2009, 94:5070-5077.
24. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000, 320:1240-1243. 10.1136/bmj.320.7244.1240, 27365, 10797032.
25. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
26. Nilsen H, Hayes B, Berg PR, Roseth A, Sundsaasen KK, Nilsen K, Lien S. Construction of a dense SNP map for bovine chromosome 6 to assist the assembly of the bovine genome sequence. Anim Genet 2008, 39:97-104. 10.1111/j.1365-2052.2007.01686.x, 18307581.
27. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942. 10.1093/bioinformatics/bti473, 15860560.
28. Dalen KT, Ulven SM, Bamberg K, Gustafsson JA, Nebb HI. Expression of the insulin-responsive glucose transporter GLUT4 in adipocytes is dependent on liver X receptor alpha. J Biol Chem 2003, 278:48283-48291. 10.1074/jbc.M302287200, 12970362.
29. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265. 10.1093/bioinformatics/bth457, 15297300.
30. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007, 23:1038-1039. 10.1093/bioinformatics/btm058, 17308338.
31. Dahlman I, Nilsson M, Gu HF, Lecoeur C, Efendic S, Ostenson CG, Brismar K, Gustafsson JA, Froguel P, Vaxillaire M, Dahlman-Wright K, Steffensen KR. Functional and genetic analysis in type 2 diabetes of liver X receptor alleles--a cohort study. BMC Med Genet 2009, 10:27. 10.1186/1471-2350-10-27, 2664799, 19292929.
32. Dahlman I, Nilsson M, Jiao H, Hoffstedt J, Lindgren CM, Humphreys K, Kere J, Gustafsson JA, Arner P, Dahlman-Wright K. Liver X receptor gene polymorphisms and adipose tissue expression levels in obesity. Pharmacogenet Genomics 2006, 16:881-889. 10.1097/01.fpc.0000236334.49422.48, 17108812.